VCM
ETON icon

Voleon Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Voleon Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Sell
7,227
-6,063
-46% -$178K ﹤0.01% 700
2026
Q1 		$328K Sell
13,290
-2,292
-15% -$40.1K 0.01% 655
2025
Q4 		$263K Buy
15,582
+4,632
+42% +$81.5K 0.01% 687
2025
Q3 		$238K Buy
+10,950
New +$182K 0.01% 783

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Voleon Capital Management's ETON Position: Q2 2026 in Review

Voleon Capital Management reduced its Eton Pharmaceutcials (ETON) stake by 46% in Q2 2026, selling an estimated $178K and leaving 7,227 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Voleon Capital Management first reported a position in ETON in Q3 2025 and has held it in 4 quarters since. The position peaked at $328K in Q1 2026. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Voleon Capital Management held 7,227 shares of Eton Pharmaceutcials worth $262K as of Q2 2026.
  • Voleon Capital Management sold 6,063 Eton Pharmaceutcials shares in Q2 2026, an estimated $178K.
  • Eton Pharmaceutcials made up ﹤0.01% of Voleon Capital Management's portfolio in Q2 2026, its #700 holding.
  • Voleon Capital Management first reported a position in Eton Pharmaceutcials in Q3 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Eton Pharmaceutcials position peaked at $328K in Q1 2026.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.